RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Compass Pathways Stock

Compass Pathways ROE 2025

Compass Pathways ROE

-1

Ticker

CMPS

ISIN

US20451W1018

WKN

A2QCDR

In 2025, Compass Pathways's return on equity (ROE) was -1, a 91.09% increase from the -0.52 ROE in the previous year.

Compass Pathways Aktienanalyse

What does Compass Pathways do?

Compass Pathways PLC is a leading company specializing in the development of groundbreaking therapies for the treatment of mental illnesses. The company was founded in 2016 and is headquartered in London. Its goal is to revolutionize the treatment of depression and other mental illnesses. The business model of Compass Pathways is based on researching psychedelics as a potential treatment for patients suffering from severe depression and anxiety disorders. The company uses innovative approaches to precisely study the effects of psychedelics on the human brain and develop new therapy concepts and products from that. An important area of Compass Pathways is clinical research. The company collaborates closely with leading research institutions to understand the impacts of psychedelics on the human brain. The research results are then used to develop innovative methods for therapeutic use of psychedelics. Another important area of Compass Pathways is the development of therapeutic products. The company has developed a patented process for producing psilocybin, a substance found in hallucinogenic mushrooms. This process achieves a very high purity of the substance, enabling precise dosing and better control of its effects. The flagship product of Compass Pathways is COMP360, a medication based on psilocybin that is being developed for the treatment of depression. The medication is currently in clinical Phase 2 trials, showing promising results. If COMP360 receives approval, it has the potential to drastically change the way we treat depression. Compass Pathways is also active in other areas. The company conducts a range of research projects related to various psychedelic substances, including LSD and other hallucinogens. Another important area of Compass Pathways is training therapists and other professionals in the use of psychedelic substances. The company offers relevant courses to promote understanding of the therapeutic use of psychedelics and enable their safe and effective application for patient treatment. Overall, Compass Pathways is a company focused on the development of groundbreaking therapies for mental illnesses. Through combining cutting-edge research, innovative products, and professional education, the company has the potential to revolutionize the way we treat mental illnesses. Compass Pathways ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Compass Pathways's Return on Equity (ROE)

Compass Pathways's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Compass Pathways's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Compass Pathways's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Compass Pathways’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Compass Pathways stock

What is the ROE (Return on Equity) of Compass Pathways this year?

The ROE of Compass Pathways this year is -1 undefined.

How has the Return on Equity (ROE) of Compass Pathways developed compared to the previous year?

The ROE of Compass Pathways has increased by 91.09% increased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Compass Pathways?

A high ROE indicates that Compass Pathways generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Compass Pathways?

A low ROE can indicate that Compass Pathways is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Compass Pathways affect the company?

A change in ROE (Return on Equity) of Compass Pathways can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Compass Pathways?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Compass Pathways?

Some factors that can influence Compass Pathways's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Compass Pathways pay?

Over the past 12 months, Compass Pathways paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Compass Pathways is expected to pay a dividend of 0 USD.

What is the dividend yield of Compass Pathways?

The current dividend yield of Compass Pathways is .

When does Compass Pathways pay dividends?

Compass Pathways pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Compass Pathways?

Compass Pathways paid dividends every year for the past 0 years.

What is the dividend of Compass Pathways?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Compass Pathways located?

Compass Pathways is assigned to the 'Health' sector.

Wann musste ich die Aktien von Compass Pathways kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Compass Pathways from 10/4/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/4/2025.

When did Compass Pathways pay the last dividend?

The last dividend was paid out on 10/4/2025.

What was the dividend of Compass Pathways in the year 2024?

In the year 2024, Compass Pathways distributed 0 USD as dividends.

In which currency does Compass Pathways pay out the dividend?

The dividends of Compass Pathways are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Compass Pathways

Our stock analysis for Compass Pathways Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Compass Pathways Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.